CN105315159B - A kind of method for splitting of compound - Google Patents

A kind of method for splitting of compound Download PDF

Info

Publication number
CN105315159B
CN105315159B CN201410415353.8A CN201410415353A CN105315159B CN 105315159 B CN105315159 B CN 105315159B CN 201410415353 A CN201410415353 A CN 201410415353A CN 105315159 B CN105315159 B CN 105315159B
Authority
CN
China
Prior art keywords
formula
rac
splitting
compound
nitroolefin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410415353.8A
Other languages
Chinese (zh)
Other versions
CN105315159A (en
Inventor
韩波
彭成
谢欣
黄维
李想
杨磊
冷海军
王彪
赵倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu University of Traditional Chinese Medicine
Original Assignee
Chengdu University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu University of Traditional Chinese Medicine filed Critical Chengdu University of Traditional Chinese Medicine
Priority to CN201410415353.8A priority Critical patent/CN105315159B/en
Publication of CN105315159A publication Critical patent/CN105315159A/en
Application granted granted Critical
Publication of CN105315159B publication Critical patent/CN105315159B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a kind of method for splitting of compound.Method for splitting of the present invention, it is easy to operate, without especially being reacted using the intermediate for possessing optical siomerism, it is possible to simply and effectively split and obtain (S) 3 chipal compounds, new selection is provided for the chiral resolution of related compound.

Description

A kind of method for splitting of compound
Technical field
The present invention relates to a kind of method for splitting of compound.
Background technology
Chiral factor biology, chemistry and other it is multi-field in all there is extremely important influence power.With organising Learn and biochemical development, the Chiral properties of compound have started to more and more be paid attention to.Numerous researchs show, different Optical isomer may have completely different physiologically active, transporting mechanism, metabolic rate and toxicity, absorb, distribution and Also it is not quite similar in terms of excretion.
Chiral resolution (Chiral resolution), also known as optical resolution (Optical resolution) or racemic Body is split, and is in spatial chemistry, to separate method of the racemic compound as two different mirror image isomerism things.Generally make Method for splitting has crystallization Split Method, chemical resolution method, enzymatic isolation method and column chromatography etc., wherein, chemical resolution method is normal Reaction is participated in using a pure optical activity isomer, forms diastereomer, then diastereomer backward reaction is sloughed to pure light Active isomer.But and not all compound can find suitable optical activity isomer and participate in reaction, if can Find a kind of method that compound can be just split without using specific optical activity isomer, it will provide newly for chiral separation method Thinking and selection.
The content of the invention
It is an object of the invention to provide a kind of chiral separation method of compound.
Specifically, the invention provides the method for splitting of (S) -3 compound as follows, reaction path are as follows:
Rac-3 isRacemic modification;
R1 is selected from phenyl ring, substituted benzene ring or five yuan or hexa-member heterocycle, R2 and is selected from C1-C4 alkyl, and R3 is selected from H or C1-C4 alkane Base.
Further, the substituent of the substituted-phenyl is selected from halogen or nitro, and substituent quantity is 1~3.
Further, the halogen is selected from F, Cl or Br.
Further, substituent quantity is 1 or 2.
Further, the C1-C4 alkyl is selected from methyl or ethyl.
Further, concrete operation step is as follows:
Rac-3 is taken to add aldehyde 4, diphenylprolinol silicon ether IIa and glacial acetic acid, reaction is carried out, monitored with TLC at room temperature Terminate to reaction, concentrate simultaneously silica gel column chromatography (PE/EA=10:1) the isolated MBH products (S) -3 of priority and chiral tetrahydrochysene pyrrole Mutter alcohol product 5.
Further, Rac-3 preparation method is:
Wherein, the concrete operation step of Rac-3 preparation methods is as follows:
Nitroolefin 1 and carbonyls 2 make solvent in the presence of DMAP with MeCN, are stirred at room temperature to obtain MBH additions production Thing rac-3.
MBH is Belize-Harry Hillman reaction.
Further, nitroolefin shown in formula 1:Carbonyls shown in formula 2:DMAP:Aldehyde shown in formula 4:Catalyst:Ice Acetic acid=0.5-1.0mmol:1.0mmol:0.05-0.2mmol:1.0-2.0mmol:0.1-0.3mmol:0.1-0.2mmol.
Preferably, nitroolefin shown in formula 1:Carbonyls shown in formula 2:DMAP:Aldehyde shown in formula 4:Catalyst:Glacial acetic acid =0.5mmol:1.0mmol:0.05mmol:1.0mmol:0.1mmol:0.1mmol.
Method for splitting of the present invention, it is easy to operate, without especially being reacted using the intermediate for possessing optical siomerism, so that it may Simply and effectively to split to obtain (S) -3 chipal compounds, new selection is provided for the chiral resolution of related compound.
Below by way of embodiment, the present invention is described in further detail, but is not intended to limit the present invention, ability Field technique personnel can be variously modified and deform according to the present invention, without departing from the spirit of the present invention, all should belong to this Invention scope of the following claims.
Embodiment
1 method for splitting of the present invention of embodiment
Nitroolefin 1 (0.5mmol) and active carbonyls 2 (1.0mmol) DMAP (6.1mg, In the presence of 0.05mmol), solvent is done with MeCN, 30min is stirred at room temperature and obtains MBH addition compound products rac-3.Then one kettle way adds Enter aldehyde 4 (1.0mmol), diphenylprolinol silicon ether IIa (32.5mg, 0.1mmol) and glacial acetic acid (6.0mg, 0.1mmol).Instead It should at room temperature carry out, reaction process is monitored with TLC.Concentrate simultaneously silica gel column chromatography (PE/EA=10:1) the isolated MBH of priority Product (S) -3 and chiral oxinane alcohol product 5.
Each particular compound split is as follows:
(d, J=7.6Hz, 2H), 5.35 (d, J=4.8Hz, 1H), 5.18 (dd, J=9.6Hz, J=6.0Hz, 1H), 5.07 (d, J= 5.6Hz, 1H), 4.26-4.20 (m, 2H), 4.03 (br s, 1H), 3.16 (t, J=11.6Hz, 1H), 1.97-1.94 (m, 1H), 1.24 (t, J=7.2Hz, 3H), 0.86 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR(100MHz,CDCl3):δ= 167.95,137.63,129.11,128.07,128.00,98.15,89.72,69.35,62.29,48.19,39.32,15.50, 13.85ppm;ESI HRMS:Calculated value C15H19NO6+ Na 332.1110, measured value 332.1112.
[α]D 20+ 108.4 (c=0.21in CH2Cl2).
1H), 7.31-7.19 (m, 3H), 5.30 (br s, 2H), 5.10 (d, J=4.8Hz, 1H), 4.34 (br s, 1H), 4.30-4.23 (m, 2H), 2.12-2.05 (m, 1H), 1.25 (t, J=6.8Hz, 3H), 0.88 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR (100MHz,CDCl3):δ=167.89,130.43,130.26,129.13,128.32,127.67,127.40,98.39, 95.33,83.64,69.98,68.89,62.38,15.08,13.88ppm;ESI HRMS:calcd.For C15H18ClNO6+Na 366.0720 measured value 366.0716.
(S)-3b:Spectral data is consistent with racemic product 3b.Yield:39% (55.7mg) is efficient Liquid phase CelluCoat posts measure ee values 98% (5%2-propanol/n-hexane, 1mL/min), UV 220nm, tminor= 13.24min,tmajor=14.23min. optically-actives:[α]D 20+ 86.2 (c=0.11in CH2Cl2).
7.20 (s, 1H), 7.10-7.08 (m, 1H), 5.34 (dd, J=7.6Hz, J=4.4Hz, 1H), 5.13 (dd, J=10.4Hz, J =6.0Hz, 1H), 5.04 (d, J=5.6Hz, 1H), 4.28-4.21 (m, 2H), 3.46 (d, J=4.0Hz, 1H), 3.21-3.15 (m, 1H), 1.95-1.85 (m, 1H), 1.26 (t, J=7.2Hz, 3H), 0.87 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR (100MHz,CDCl3):δ=167.64,139.71,135.02,130.40,128.41,128.09,126.32,97.82, 88.98,69.60,62.34,47.65,39.49,15.36,13.87ppm;High resolution mass spectrum ESI HRMS:Calculated value C15H18ClNO6+ Na 366.0720, measured value 366.0723.
2-propanol/n-hexane,1mL/min),UV 220nm,tminor=10.13min, tmajor=19.33min. optically-actives: [α]D 20+ 97.6 (c=0.15in CH2Cl2).
δ=7.35 (d, J=8.0Hz, 2H), 7.14 (d, J=7.6Hz, 2H), 5.33 (d, J=6.8Hz, 1H), 5.13 (dd, J= 10.0Hz, J=6.0Hz, 1H), 5.06 (d, J=5.6Hz, 1H), 4.26-4.20 (m, 2H), 4.06 (br s, 1H), 3.15 (t, J=11.2Hz, 1H), 1.95-1.89 (m, 1H), 1.24 (t, J=7.2Hz, 3H), 0.85 (d, J=6.4Hz, 3H) ppm;Carbon Spectrum13C NMR(100MHz,CDCl3):δ=166.80,135.12,132.96,128.34,128.31,96.94,88.37, 68.25,61.35,46.58,38.26,14.41,12.82ppm;High resolution mass spectrum ESI HRMS:Calculated value C15H18ClNO6+Na 366.0720 measured value 366.0723.
(S)-3d:Spectral data yields consistent with racemic product 3d:38% (54.3mg) efficient liquid phase AD-H posts determine Ee values 98% (10%2-propanol/n-hexane, 1mL/min), UV 220nm, tminor=16.01min, tmajor= 30.78min. optically-actives:[α]D 20+ 82.4 (c=0.12in CH2Cl2).
CDCl3):δ=7.44 (s, 1H), 7.31-7.21 (m, 2H), 5.28 (br s, 2H), 5.07 (d, J=4.4Hz, 1H), 4.32- 4.23 (m, 2H), 4.09 (br s, 1H), 3.92-3.80 (m, 1H), 2.05 (br s, 1H), 1.25 (t, J=7.2Hz, 3H), 0.87 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR(100MHz,CDCl3):δ=167.68,134.37,130.25, 130.08,128.07,127.74,127.67,98.19,95.18,83.25,69.86,69.01,62.44,14.99, 13.88ppm;High resolution mass spectrum ESI HRMS:calcd.For C15H17Cl2NO6+ Na 400.0331, measured value 400.0328.
Optically-active:[α]D 20+ 76.9 (c=0.21in CH2Cl2).
CDCl3):δ=7.45 (d, J=8.4Hz, 1H), 7.37 (s, 1H), 7.24-7.23 (m, 1H), 7.14 (d, J=7.6Hz, 1H), 5.32 (d, J=7.2Hz, 1H), 5.15 (dd, J=9.6Hz, J=5.6Hz, 1H), 5.07 (d, J=5.6Hz, 1H), 4.44 (br S, 1H), 4.25-4.20 (m, 2H), 3.14 (t, J=11.2Hz, 1H), 1.97-1.89 (m, 1H), 1.24 (t, J=7.2Hz, 3H), 0.87 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR(100MHz,CDCl3):δ=166.91,139.13,130.29, 129.95,129.64,125.83,122.14,96.99,88.27,68.11,61.41,46.89,38.22,14.52, 12.82ppm;High resolution mass spectrum ESI HRMS:Calculated value C15H18BrNO6+ Na 410.0215, measured value 410.0211.
(S)-3f:Spectral data is consistent with racemic product 3f.Yield:41% (67.7mg) is high Imitate liquid phase AD-H posts measure ee values 90% (15%2-propanol/n-hexane, 1mL/min), UV 220nm, tminor= 9.80min,tmajor=18.88min. optically-actives:[α]D 20+ 65.8 (c=0.16in CH2Cl2).
CDCl3):δ=7.50 (d, J=7.6Hz, 2H), 7.08 (d, J=7.6Hz, 2H), 5.33 (d, J=4.0Hz, 1H), 5.12 (dd, J=9.6Hz, J=6.0Hz, 1H), 5.05 (d, J=5.2Hz, 1H), 4.25-4.21 (m, 2H), 4.08 (br s, 1H), 3.14 (t, J=11.2Hz, 1H), 1.95-1.88 (m, 1H), 1.24 (t, J=7.2Hz, 3H), 0.85 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR(100MHz,CDCl3):δ=166.80,135.66,131.29,128.65,121.05,96.91, 88.26,68.27,61.36,46.65,38.23,14.40,12.82ppm;High resolution mass spectrum ESI HRMS:Calculated value C15H18BrNO6+ Na 410.0215, measured value 410.0217.
min,tmajor=32.45min. optically-actives:[α]D 20+ 87.2 (c=0.16in CH2Cl2).
CDCl3):δ=7.19-7.16 (m, 2H), 7.08-7.04 (m, 2H), 5.35-5.33 (m, 1H), 5.13 (dd, J=9.6Hz, J =6.0Hz, 1H), 5.06 (d, J=5.6Hz, 1H), 4.29-4.17 (m, 3H), 3.15 (t, J=11.2Hz, 1H), 1.96- 1.90 (m, 1H), 1.24 (t, J=7.2Hz, 3H), 0.85 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR(100MHz, CDCl3):δ=167.93,162.36 (d, JCF=246Hz), 133.38 (d, JCF=3Hz), 129.59 (d, JCF=8Hz), 116.14(d,JCF=21Hz), 98.08,89.76,69.19,62.38,47.57,39.35,15.49,13.84ppm;High-resolution Mass spectrum ESI HRMS:Calculated value C15H18FNO6+ Na 350.1016, measured value 350.1011.
(S)-3h:Spectral data yields consistent with racemic product 3h:36% (48.5mg) efficient liquid phase AD-H posts determine Ee values 99% (15%2-propanol/n-hexane, 1mL/min), UV 220nm, tminor=12.73min, tmajor= 24.56min. optically-actives:[α]D 20+ 75.4 (c=0.20in CH2Cl2).
7.67 (t, J=7.6Hz, 1H), 7.51-7.47 (m, 2H), 5.35-5.21 (m, 2H), 5.12 (d, J=5.2Hz, 1H), 4.32- 4.18 (m, 3H), 4.03 (br s, 1H), 2.08 (br s, 1H), 1.25 (t, J=7.2Hz, 3H), 0.85 (d, J=6.4Hz, 3H)ppm;Carbon is composed13C NMR(100MHz,CDCl3):δ=167.62,133.51,133.05,128.91,128.08,125.19, 124.96,97.91,95.17,88.35,83.98,69.70,62.52,13.85,13.43ppm;High resolution mass spectrum ESI HRMS: Calculated value C15H18N2O8+ H355.1141, measured value 355.1145.
tmajor=34.45min. optically-actives:[α]D 20+ 91.6 (c=0.16in CH2Cl2).
CDCl3):δ=8.25 (d, J=8.4Hz, 2H), 7.42 (d, J=8.4Hz, 2H), 5.35 (dd, J=6.8Hz, J=4.4Hz, 1H), 5.18 (dd, J=10.0Hz, J=6.0Hz, 1H), 5.10 (d, J=5.6Hz, 1H), 4.31-4.19 (m, 2H), 3.80 (d, J=3.6Hz, 1H), 3.34 (t, J=11.2Hz, 1H), 2.01-1.95 (m, 1H), 1.26 (t, J=7.2Hz, 3H), 0.86 (d, J=6.4Hz, 3H) ppm;Carbon is composed13C NMR(100MHz,CDCl3):δ=167.58,147.73,145.19,129.08, 124.39,97.64,88.44,69.45,62.51,47.80,39.45,15.31,13.86ppm;High resolution mass spectrum ESI HRMS: Calculated value C15H18N2O8+ Na 377.0961, measured value 377.0958.
min,tmajor=24.45min. optically-actives:[α]D 20+ 65.8 (c=0.22in CH2Cl2).

Claims (4)

1. the method for splitting of (S) -3 compound as follows, it is characterised in that:Reaction path is as follows:
Rac-3 isRacemic modification;
R1Selected from phenyl ring, substituted benzene ring or five yuan or hexa-member heterocycle, R2Selected from C1-C4 alkyl, R3Selected from H or C1-C4 alkyl;
Wherein, the substituent of the substituted-phenyl is selected from halogen or nitro;The halogen is selected from F, Cl or Br;Substituent quantity is 1 or 2;
Concrete operation step is as follows:
Rac-3 is taken to add aldehyde 4, diphenylprolinol silicon ether and glacial acetic acid, reaction is carried out, monitored with TLC to reaction at room temperature Terminate, concentrate and pass through silica gel column chromatography, petrol ether/ethyl acetate=10:The isolated MBH products (S) -3 of 1 elution and chirality Oxinane alcohol product 5;
Rac-3 preparation method is:
Nitroolefin 1 and carbonyls 2 make solvent in the presence of DMAP with MeCN, are stirred at room temperature to obtain MBH addition compound products Rac-3。
2. method for splitting according to claim 1, it is characterised in that:The C1-C4 alkyl is selected from methyl or ethyl.
3. method for splitting according to claim 1, it is characterised in that:Nitroolefin shown in formula 1:Carbonyl compound shown in formula 2 Thing:DMAP:Aldehyde shown in formula 4:Diphenylprolinol silicon ether:Glacial acetic acid=0.5-1.0mmol:1.0mmol:0.05-0.2mmol: 1.0-2.0mmol:0.1-0.3mmol:0.1-0.2mmol.
4. method for splitting according to claim 3, it is characterised in that:Nitroolefin shown in formula 1:Carbonyl compound shown in formula 2 Thing:DMAP:Aldehyde shown in formula 4:Diphenylprolinol silicon ether:Glacial acetic acid=0.5mmol:1.0mmol:0.05mmol:1.0mmol: 0.1mmol:0.1mmol.
CN201410415353.8A 2014-06-26 2014-08-21 A kind of method for splitting of compound Expired - Fee Related CN105315159B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410415353.8A CN105315159B (en) 2014-06-26 2014-08-21 A kind of method for splitting of compound

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2014102988129 2014-06-26
CN201410298812 2014-06-26
CN201410415353.8A CN105315159B (en) 2014-06-26 2014-08-21 A kind of method for splitting of compound

Publications (2)

Publication Number Publication Date
CN105315159A CN105315159A (en) 2016-02-10
CN105315159B true CN105315159B (en) 2017-12-15

Family

ID=55243562

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410415353.8A Expired - Fee Related CN105315159B (en) 2014-06-26 2014-08-21 A kind of method for splitting of compound

Country Status (1)

Country Link
CN (1) CN105315159B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105315248A (en) * 2014-06-26 2016-02-10 成都中医药大学 Tetrahydropyranol series chiral compound, synthesis method therefor and use of tetrahydropyranol series chiral compound

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105315248A (en) * 2014-06-26 2016-02-10 成都中医药大学 Tetrahydropyranol series chiral compound, synthesis method therefor and use of tetrahydropyranol series chiral compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Asymmetric One-Pot Four-Component Coupling Reaction: Synthesis of Substituted Tetrahydropyrans Catalyzed by Diphenylprolinol Silyl Ether;Hayato Ishikawa等;《Angew. Chem.》;20110324;第123卷;3858-3863 *

Also Published As

Publication number Publication date
CN105315159A (en) 2016-02-10

Similar Documents

Publication Publication Date Title
Takiguchi et al. Total syntheses of (−)-fructigenine A and (−)-5-N-acetylardeemin
CN103641827B (en) Purrocoline derivative and synthetic method and application thereof
Viji et al. Regiodivergent Organocatalytic Reactions
Nascimento et al. Stereoselective synthesis of 8, 9-licarinediols
CN103965093A (en) 2-perfluoroalkyl indole compound as well as preparation and application thereof
CN105837494A (en) Difluoroalky lindolone derivative and preparation method thereof
CN105315159B (en) A kind of method for splitting of compound
CN111072605B (en) Preparation method of fluoroalkyl-substituted benzofuran derivative or indole derivative
Zhang et al. N-heterocyclic carbene-mediated formal [3+ 3] annulation of isatin-derived α, β-unsaturated acids: Access to functionalized 3, 4′-spirooxindole δ-lactones
CN104892485B (en) 2 perfluoroalkyl indole derivativeses and its synthetic method
CN105646327A (en) 2-perfluoroalkyl indole derivative and synthesis method thereof
CN112279765B (en) Preparation method of chiral alpha-fluoroketone compound
CN101891678B (en) 4-(N,N-dimethyl) aminopyridine derivate and synthesis method thereof
CN115010753A (en) Method for preparing phosphorylated gem-difluorodiene compound in aqueous phase
Xie et al. Asymmetric synthesis of oxa-spirocyclic indanones with structural complexity via an organocatalytic Michael–Henry–acetalization cascade
Konishi et al. First enantioselective synthesis of exiguamide, a nitrogen-containing spirocyclic sesquiterpene isolated from the marine sponge Geodia exigua
CN108299369B (en) Coumarin-4-sulfonic acid ester derivative and preparation method thereof
CN105384715A (en) Preparation method of 7-substituted 3-bromo-4-phenylcoumarin series compounds
CN114907246A (en) Total synthesis method of vitamin A, derivative thereof and deuterated compound thereof
Kobayashi et al. Highly stereocontrolled total synthesis of secodolastane diterpenoid isolinearol
CN106045842A (en) Method for preparing loxoprofen active metabolite
CN107382640B (en) β -aryl phenylpropanone compound synthesis method
CN105859557B (en) A kind of preparation method of esters of alpha, beta, unsaturated carboxylic acids compound
CN112299996B (en) Synthesis method of chiral alpha-deuterated ketone
Alvarez et al. Enantioselective synthesis of all of the stereoisomers of (E)-13, 14-dihydroxyretinol (DHR)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171215

Termination date: 20200821

CF01 Termination of patent right due to non-payment of annual fee